{"id":13239,"date":"2020-12-24T00:01:00","date_gmt":"2020-12-24T00:01:00","guid":{"rendered":"https:\/\/clinlabint.3wstaging.nl\/trimero-diagnostics-introduces-serum-amyloid-a-nephelometric-assay\/"},"modified":"2021-01-14T11:32:35","modified_gmt":"2021-01-14T11:32:35","slug":"trimero-diagnostics-introduces-serum-amyloid-a-nephelometric-assay","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/trimero-diagnostics-introduces-serum-amyloid-a-nephelometric-assay\/","title":{"rendered":"TRIMERO Diagnostics introduces Serum Amyloid A nephelometric assay"},"content":{"rendered":"
TRIMERO Diagnostics has introduced an IVD CE-marked assay for testing Serum Amyloid A (SAA) on Beckman Coulter’s IMMAGE immunochemical systems.
\nThe key features of the assay are:<\/p>\n
SAA turbidimetric assays are also available for the most popular clinical chemistry analysers.
\nOther available assays for IMMAGE nephelometers and turbidimetry include: KLoneus Free Light Chains (FLC) for serum and urine, Beta-2 Microglobulin for serum and urine, IgD Immunoglobulins, Retinol Binding Protein (RBP) for serum and urine, Soluble Transferrin Receptor (sTfR), Hemopexin, Cystatin-C for serum and urine, A1-Microglobulin, Kappa and Lambda Light Chains for serum and urine, Complement C1q, Complement C5, Factor B (C3 Proactivator), C1 (Esterase) Inhibitor.
\nFor more information, visit: www.3diag.com<\/link>\n
\nSupplier:<\/strong> TRIMERO DIAGNOSTICS
\nWebsite:<\/strong> http:\/\/www.3diag.com\/<\/a><\/p>\n